Medinet
Medinet is a total solution provider for cell processing, including contract manufacturing of specific cell processed products (CMO) and development/manufacturing of regenerative medicine products (CDMO).
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Medinet Co., Ltd. is a Japanese company established in October 1995. It provides total solutions for cell processing, including contract manufacturing of specific cell processed products (CMO) and development/manufacturing of regenerative medicine products (CDMO). The company also offers value chain services and operates a self-cancer tissue bank.
History
Medinet was established in October 1995 in Minato-ku, Tokyo, with the aim of providing new medical services based on preventive medicine. In 1999, it opened the Molecular Immunology Laboratory and began supporting immunotherapy. The company was listed on the Tokyo Stock Exchange Mothers market in October 2003. In 2004, it started the 'Self-Cancer Tissue Bank' service. Over the years, it has expanded its facilities and services, including obtaining manufacturing permits for specific cell processed products and entering into various contracts and collaborations.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/medinet · Editorial policy · How profiles are compiled